Skip to the page

Data / Drug companies / Anastrozole

Anastrozole: 22 companies and 34 products in the FDA NDC directory

Anastrozole is listed in the FDA National Drug Code Directory by 22 companies, with 34 products in commercial distribution. 33 of the products (97.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, coated; tablet, film coated, and the newest product started marketing on August 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
22
Products
34
Generic (ANDA) products
33 (97.1%)
Application numbers
7
Routes
Oral
Brand names
Arimidex
openFDA record search
api.fda.gov

Companies that list anastrozole

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
NuCare Pharmaceuticals,Inc.7tabletGeneric drugs (ANDA)June 28, 2010
PD-Rx Pharmaceuticals, Inc.3tablet; tablet, coatedGeneric drugs (ANDA)June 22, 2026
A-S Medication Solutions2tabletGeneric drugs (ANDA)June 28, 2010
AvKARE2tablet, film coated; tabletGeneric drugs (ANDA)February 6, 2023
Bryant Ranch Prepack2tablet, coated; tabletGeneric drugs (ANDA)June 28, 2010
Direct_Rx2tabletGeneric drugs (ANDA)August 3, 2026
Accord Healthcare Inc.1tabletGeneric drugs (ANDA)June 22, 2010
American Health Packaging1tablet, coatedGeneric drugs (ANDA)February 3, 2016
Ani Pharmaceuticals, Inc.1tabletNew drug applications (NDA)June 26, 2018
Asclemed USA, Inc.1tabletGeneric drugs (ANDA)June 22, 2010
Aurobindo Pharma Limited1tablet, film coatedGeneric drugs (ANDA)July 24, 2020
AvPAK1tabletGeneric drugs (ANDA)October 11, 2019
BluePoint Laboratories1tablet, coatedGeneric drugs (ANDA)January 1, 2014
Breckenridge Pharmaceutical, Inc.1tabletGeneric drugs (ANDA)June 28, 2010
Bryant Ranch Prepack1tabletGeneric drugs (ANDA)June 22, 2010
Chartwell RX, LLC1tabletGeneric drugs (ANDA)February 28, 2019
Natco Pharma Limited1tabletGeneric drugs (ANDA)June 28, 2010
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)June 28, 2010
Proficient Rx LP1tabletGeneric drugs (ANDA)June 28, 2010
Teva Pharmaceuticals USA, Inc.1tablet, film coatedGeneric drugs (ANDA)June 28, 2010
Zydus Lifesciences Limited1tablet, coatedGeneric drugs (ANDA)June 27, 2010
Zydus Pharmaceuticals USA Inc.1tablet, coatedGeneric drugs (ANDA)June 27, 2010

Dosage forms

Dosage formProductsShare
Tablet2470.6%
Tablet, coated617.6%
Tablet, film coated411.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3397.1%
New drug applications (NDA)12.9%

Pharmacologic classes

ClassProducts
Aromatase Inhibitor34

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.